Efficacy and Safety of ATO Plus ATRA in Nucleophosmin-1 Mutated Acute Myeloid Leukemia
Clinical trial NCT03031249 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT03031249
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-08
- Primary completion
- 2026-05-15
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.